Karen Chung currently serves as the VP of Health Economics & Market Access at Viking Therapeutics, Inc., a position held since September 2024. Previously, Karen was the Head of Health Economics & Outcomes Research at GRAIL from May 2019 to August 2024. Prior experience includes holding senior roles at Juno Therapeutics, Inc., Jazz Pharmaceuticals, Gilead Sciences, and Amgen, with a focus on health economics and outcomes research. Earlier career positions were at Baxter Healthcare and Bayer Pharmaceuticals, contributing to clinical development and health economics. Educational qualifications include a Doctor of Pharmacy from the University of Southern California and an MS in Pharmacy Administration from the University of Arizona.
This person is not in the org chart
This person is not in any teams